Neothera
PrivateLast Round
Pre Seed
Jul 9, 2026
Total Funding Raised
$2.13M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neothera is a health-tech company that provides an integrated skin health platform focused on treating chronic skin conditions like acne through root-cause diagnostics, personalized habit interventions, and clinically validated formulations.
Sector
Healthcare & Life Sciences
Verticals
Fashion & Beauty, D2C Brands, Medical AI
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neothera Comparables
Compare Neothera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MDalgorithms | 78% | |
| CureSkin | 77% | |
| MDacne | 76% | |
Neothera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 9, 2026 | ||||
| Pre Seed | Aug 1, 2025 |
Neothera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blume Ventures | Pre Seed |
| Veltis Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 9, 2026
$1.08M round led by Blume Ventures
Neothera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neothera's valuation, stock price, and market status.